Trademark: 77223471
Status Date
Monday, August 29, 2011
Filing Date
Friday, July 6, 2007
Published for Opposition
Tuesday, May 6, 2008
Abandoned Date
Monday, August 29, 2011
5 pharmaceutical preparations, namely, biopharmaceuticals based on human monoclonal antibodies for the treatment of immune and inflammatory diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, central nervous system diseases and disorders, and infectious-related diseases and disorders
10 syringes for medical purposes and for injections
Aug 29, 2011
Abandonment Notice Mailed - No Use Statement Filed
Aug 29, 2011
Abandonment - No Use Statement Filed
Jan 20, 2011
Notice Of Approval Of Extension Request Mailed
Jan 19, 2011
Extension 5 Granted
Jan 17, 2011
Extension 5 Filed
Jan 17, 2011
Teas Extension Received
Jul 24, 2010
Notice Of Approval Of Extension Request Mailed
Jul 23, 2010
Extension 4 Granted
Jul 20, 2010
Extension 4 Filed
Jul 20, 2010
Teas Extension Received
Jan 28, 2010
Extension 3 Granted
Jan 27, 2010
Extension 3 Filed
Jan 27, 2010
Teas Extension Received
Jul 22, 2009
Extension 2 Granted
Jul 20, 2009
Extension 2 Filed
Jul 20, 2009
Teas Extension Received
Jan 22, 2009
Extension 1 Granted
Jan 7, 2009
Extension 1 Filed
Jan 22, 2009
Case Assigned To Intent To Use Paralegal
Jan 7, 2009
Teas Extension Received
Jul 29, 2008
Noa Mailed - Sou Required From Applicant
May 6, 2008
Published For Opposition
Apr 16, 2008
Notice Of Publication
Apr 1, 2008
Law Office Publication Review Completed
Apr 1, 2008
Assigned To Lie
Mar 22, 2008
Approved For Pub - Principal Register
Mar 6, 2008
Teas/Email Correspondence Entered
Mar 6, 2008
Correspondence Received In Law Office
Mar 6, 2008
Teas Response To Office Action Received
Sep 7, 2007
Non-Final Action Mailed
Sep 6, 2007
Non-Final Action Written
Sep 6, 2007
Assigned To Examiner
Jul 11, 2007
Notice Of Pseudo Mark Mailed
Jul 10, 2007
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
